Zhou, Hong

Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy

Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews

Bone health and osteoporosis researchAdrenal Hormones and Disorders

Cited by 258

Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury

Soriano, S. G., Amaravadi, L. S., Wang, Y. F., Zhou, H., Yu, G. X., Tonra, J. R., Fairchild-Huntress, V., Fang, Q., Dunmore, J. H., Huszar, D., et al. (2002) · Journal of Neuroimmunology

Neuroinflammation and Neurodegeneration MechanismsChemokine receptors and signaling

Cited by 222

Glucocorticoids and bone: Local effects and systemic implications

Henneicke, H., Gasparini, S. J., Brennan-Speranza, T. C., Zhou, H., & Seibel, M. J. (2014) · Trends in Endocrinology & Metabolism

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 168

Exogenous and endogenous glucocorticoids in rheumatic diseases

Buttgereit, F., Burmester, G., Straub, R. H., Seibel, M. J., & Zhou, H. (2011) · Arthritis & Rheumatism

Rheumatoid Arthritis Research and TherapiesAdrenal Hormones and Disorders

Cited by 105

Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis

Zheng, Y., Zhou, H., Brennan, K., Blair, J. M., Modzelewski, J. R. K., Seibel, M. J., & Dunstan, C. R. (2007) · Bone

Bone health and treatmentsBone Metabolism and Diseases

Cited by 82

Arthritis and the role of endogenous glucocorticoids

Macfarlane, E., Seibel, M. J., & Zhou, H. (2020) · Bone Research

Osteoarthritis Treatment and MechanismsRheumatoid Arthritis Research and Therapies

Cited by 64